Roxbury Financial’s Ascendis Pharma A/S ASND Stock Holding History

Roxbury Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.6K	Buy	+42	New	+$10.6K	0.01%	335
2026 Q2	–	Sell	-42	Closed	-$9.6K	–	412
2026 Q1	$9.6K	Hold	42	–	–	0.01%	304
2025 Q4	$8.96K	Hold	42	–	–	0.01%	302
2025 Q3	$8.35K	Hold	42	–	–	0.01%	296
2025 Q2	$7.25K	Buy	42 +32	+320%	+$5.21K	0.01%	297
2025 Q1	$1.57K	Buy	+10	New	+$1.43K	﹤0.01%	328

Other funds holding ASND

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Matisse Capital Portland, Oregon $256M AUM 15.28% 1-Year Est. Return

Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Roxbury Financial's ASND Position: Q3 2026 in Review

Roxbury Financial opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 42 shares worth $9.6K. The stake represents 0.01% of the portfolio and ranks #335 among its holdings. This is a return to the name: Roxbury Financial previously reported a position in ASND as recently as Q1 2026.

Roxbury Financial first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.6K in Q1 2026. 96 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Roxbury Financial held 42 shares of Ascendis Pharma A/S worth $9.6K as of Q3 2026.
Ascendis Pharma A/S was a new Roxbury Financial position in Q3 2026.
Ascendis Pharma A/S made up 0.01% of Roxbury Financial's portfolio in Q3 2026, its #335 holding.
Roxbury Financial first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
Roxbury Financial's Ascendis Pharma A/S position peaked at $9.6K in Q1 2026.
96 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.